Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials.

MLA

Grayling, Michael J., et al. “Improving Power in PSA Response Analyses of Metastatic Castration-Resistant Prostate Cancer Trials.” BMC Cancer, vol. 22, no. 1, Jan. 2022, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12885-022-09227-7.

APA

Grayling, M. J., McMenamin, M., Chandler, R., Heer, R., & Wason, J. M. S. (2022). Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials. BMC Cancer, 22(1), 1–8. https://doi.org/10.1186/s12885-022-09227-7

Chicago

Grayling, Michael J., Martina McMenamin, Robert Chandler, Rakesh Heer, and James M. S. Wason. 2022. “Improving Power in PSA Response Analyses of Metastatic Castration-Resistant Prostate Cancer Trials.” BMC Cancer 22 (1): 1–8. doi:10.1186/s12885-022-09227-7.